Penumbra (PEN) Share-based Compensation (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.04% |
| Dec 31, 2025 | -4.21% |
| Sep 30, 2025 | 11.93% |
| Jun 30, 2025 | 3.26% |
| Mar 31, 2025 | 13.97% |
| Dec 31, 2024 | 10.56% |
| Sep 30, 2024 | 14.44% |
| Jun 30, 2024 | -29.55% |
| Mar 31, 2024 | 25.74% |
| Dec 31, 2023 | -23.66% |
| Sep 30, 2023 | 10.24% |
| Jun 30, 2023 | 0.45% |
| Mar 31, 2023 | 27.70% |
| Dec 31, 2022 | 3.04% |
| Sep 30, 2022 | 10.43% |
| Jun 30, 2022 | -1.20% |
| Mar 31, 2022 | -78.65% |
| Dec 31, 2021 | 427.17% |
| Sep 30, 2021 | -19.38% |
| Jun 30, 2021 | 53.29% |
| Mar 31, 2021 | -20.61% |
| Dec 31, 2020 | 29.13% |
| Sep 30, 2020 | 12.21% |
| Jun 30, 2020 | -2.29% |
| Mar 31, 2020 | 13.46% |
| Dec 31, 2019 | -19.66% |
| Sep 30, 2019 | 21.54% |
| Jun 30, 2019 | 0.79% |
| Mar 31, 2019 | 4.60% |
| Dec 31, 2018 | 10.40% |
| Sep 30, 2018 | -11.49% |
| Jun 30, 2018 | 20.00% |
| Mar 31, 2018 | -11.99% |
| Dec 31, 2017 | 5.19% |
| Sep 30, 2017 | -2.31% |
| Jun 30, 2017 | 14.48% |
| Mar 31, 2017 | 4.56% |
| Dec 31, 2016 | -9.99% |
| Sep 30, 2016 | 21.04% |
| Jun 30, 2016 | 16.82% |
| Mar 31, 2016 | 40.56% |
| Dec 31, 2015 | 42.05% |
| Sep 30, 2015 | -53.70% |
| Jun 30, 2015 | 818.59% |
| Mar 31, 2015 | -1.11% |